Akanda Corp. (AKAN)

Market Cap	11.23M
Revenue (ttm)	41,431
Net Income (ttm)	-8.13M
Shares Out	34.04M
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,600,413
Open	0.357
Previous Close	0.340
Day's Range	0.313 - 0.360
52-Week Range	0.124 - 31.000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AKAN

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Mar 15, 2022
• Employees: 107
• Stock Exchange: NASDAQ
• Ticker Symbol: AKAN

Financial Performance

In 2021, Akanda's revenue was $41,431, an increase of 1909.26% compared to the previous year's $2,062. Losses were -$8.13 million, 253.4% more than in 2020.